NOP16 Antikörper (Middle Region)
Kurzübersicht für NOP16 Antikörper (Middle Region) (ABIN631833)
Target
Alle NOP16 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- HSPC111 antibody was raised against the middle region of HSPC111
-
Aufreinigung
- Affinity purified
-
Immunogen
- HSPC111 antibody was raised using the middle region of HSPC111 corresponding to a region with amino acids RKVKAMEVDIEERPKELVRKPYVLNDLEAEASLPEKKGNTLSRDLIDYVR
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
HSPC111 Blocking Peptide, (ABIN5614109), is also available for use as a blocking control in assays to test for specificity of this HSPC111 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of HSPC111 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NOP16 (Nucleolar Protein 16 (NOP16))
-
Andere Bezeichnung
- HSPC111
-
Hintergrund
- NOP16 is transcriptionally regulated by c-Myc, upregulated in breast cancer, and overexpression is associated with poor patient survival.
-
Molekulargewicht
- 21 kDa (MW of target protein)
Target
-